February 28, 2018 / 5:01 PM / 7 months ago

BRIEF-Genkyotex FY Consolidated Net Loss of 25,773 thousand euros

Feb 28 (Reuters) - GENKYOTEX SA:

* GENKYOTEX’S CASH RUNWAY EXTENDS THROUGH Q1 2019

* ‍GENKYOTEX RECORDED FY CONSOLIDATED NET LOSS OF -EUR 25,773 THOUSAND​

* TWO PHASE II CLINICAL TRIALS ONGOING FOR GKT831

* INTERIM ANALYSIS RESULTS IN PRIMARY BILIARY CHOLANGITIS EXPECTED IN FIRST HALF OF 2018

* ‍FY RECURRING OPERATING LOSS INCLUDES A SHARE-BASED PAYMENTS EXPENSE OF EUR 3,838 THOUSAND​

* ‍ON DECEMBER 31, 2017, GENKYOTEX HAD CASH, CASH EQUIVALENTS AND SHORT-TERM PLACEMENTS OF EUR 14.6 MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below